FIELD: medicine.
SUBSTANCE: the present innovation should be fulfilled due to performing sclerotherapy with 96%-ethanol under ultrasound control at the dosage of 0.5-1 ml/ml of nodal volume in case of nodal neoplasms and 3-5 ml in case of cystic neoplasm after liquid aspiration. Moreover, a day before each course of sclerotherapy one should introduce Movalis for 5-10 d once daily after meals. The course of sclerotherapy should be started with introducing 96%-ethanol, then 8-10 d later it is necessary to introduce benzyl peniccilin sodium salt at the dosage of 0.5-1 ml/ml of nodal volume in case of nodal neoplasm, and 0.5 ml after liquid aspiration - in case of cystic neoplasm. The innovation enables to decrease side manifestations of complex therapy performed due to decreasing the quantity of injections.
EFFECT: higher efficiency of therapy.
1 cl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD AND PREPARATION FOR TREATING BENIGN THYROID NEOPLASMS | 2005 |
|
RU2294195C1 |
METHOD OF TREATMENT OF THYROID GLAND DIFFUSE-NODULAR GOITER | 2007 |
|
RU2336895C1 |
METHOD FOR PREDICTING EFFICIENCY IN TREATING THYROID CYSTS DUE TO PERCUTANEOUS ETHANOL SCLEROTHERAPY | 2004 |
|
RU2291430C2 |
METHOD OF SURGICAL MANAGEMENT OF BENIGN PALPABLE THYROID ABNORMALITIES | 2010 |
|
RU2438604C1 |
METHOD AND PREPARATION FOR TREATING AUTOIMMUNE THYROIDITIS | 2005 |
|
RU2297226C1 |
METHOD OF TWO-STAGE COMBINED DESTRUCTION OF BENIGN THYROID NODULES | 2009 |
|
RU2402359C1 |
METHOD OF ETHANOL SCLEROTHERAPY OF CYSTIC TRANSFORMED THYROID NODULES | 2009 |
|
RU2446791C2 |
METHOD OF COMBINED DESTRUCTION OF BENIGN SOLID NODULES OF THYROIDS GLAND | 2009 |
|
RU2426565C2 |
METHOD FOR TREATMENT AND PREVENTION OF NODULAR GOITER | 2010 |
|
RU2438678C2 |
METHOD FOR TWO-STAGE TREATMENT OF NODULAR TOXIC GOITER | 2023 |
|
RU2820877C1 |
Authors
Dates
2005-12-10—Published
2003-12-02—Filed